25/11/2025
Scientists at Cancer Research UK in London have developed a groundbreaking genome sequencing test that can predict bowel cancer risk in people with inflammatory bowel disease (IBD), including Crohn’s and Colitis. This innovative test analyzes DNA changes in the bowel lining with over 90% accuracy, offering hope for earlier detection and personalized care. This is a major step forward for our community, led by a world-class research institution dedicated to fighting cancer.
As someone passionate about raising awareness for Crohn’s and Colitis, it’s encouraging to see science advancing toward better health outcomes for our community. Early detection saves lives, stay informed about these important developments, and talk to your healthcare provider about what this might mean for your care.